ProShare Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,036
Closed -$4.44K 1978
2023
Q3
$4.44K Buy
+10,036
New +$4.58K ﹤0.01% 1815
2023
Q2
Sell
-23,174
Closed -$42.2K 1930
2023
Q1
$42.2K Sell
23,174
-3,195
-12% -$6.94K ﹤0.01% 1685
2022
Q4
$54.6K Buy
26,369
+14,366
+120% +$45.4K ﹤0.01% 1731
2022
Q3
$37K Sell
12,003
-104
-0.9% -$369 ﹤0.01% 1684
2022
Q2
$38K Buy
+12,107
New +$65.6K ﹤0.01% 1733

Other funds holding HLTH

ProShare Advisors's HLTH Position: Q4 2023 in Review

ProShare Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 10,036 shares — an estimated $4.44K sold.

ProShare Advisors first reported a position in HLTH in Q2 2022 and held it in 5 quarters. The position peaked at $54.6K in Q4 2022. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • ProShare Advisors reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • ProShare Advisors sold 10,036 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $4.44K.
  • ProShare Advisors first reported a position in Cue Health Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • ProShare Advisors's Cue Health Inc. Common Stock position peaked at $54.6K in Q4 2022.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on ProShare Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.